OTC · GABLF
GABY Inc.
$0.00+$0.00 (+45.0%)
GABY Inc.: Healthcare · Medical - Pharmaceuticals.
Loading market information…
OTC · KALO · USD
Stock price, earnings
Quote as of Nov 14, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kallo Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Kallo Inc., along with its affiliated companies, specializes in the development of software solutions for the medical information technology sector. The company's current development pipeline features an Electronic Medical Records (EMR) Integration Engine, which is designed to connect diverse applications, both within and external to healthcare facilities, with EMR systems. Other solutions under development include an internet-based Communicable and Infectious Disease Information Management System for tracking and managing health data, and a technology aimed at facilitating clinical care on a global scale. Kallo Inc.'s existing product portfolio encompasses MC-Telehealth, a mobile clinic system equipped with telehealth capabilities. They also offer the Kallo Integrated Delivery System (KIDS), a comprehensive framework of technology and processes that defines the components of their various products and services. Additionally, they provide KIDS Global Tele-Health Ecosystems, a full-fledged telehealth program designed to deliver virtual medical care, health promotion, disease prevention, and patient education to individuals within the KIDS network. The company, formerly known as Diamond Technologies Inc., was incorporated in 2006 and maintains its headquarters in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:29 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+45.0%)
GABY Inc.: Healthcare · Medical - Pharmaceuticals.
$0.00$0.00 (0.0%)
Empower Clinics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.04-$0.00 (-2.67%)
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.37% below the high.
$0.00-$0.00 (-85.71%)
RCMW Group, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01+$0.01 (+166.67%)
Silo Wellness Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.50+$0.17 (+51.52%)
Irwin Naturals Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.27% below the high.
$0.08-$0.09 (-51.52%)
Parnell Pharmaceuticals Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 77.14% below the high.
$0.00-$0.00 (-15.56%)
AusCann Group Holdings Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.
